While it is wise to be cautious, there are significant savings available to those who know what to look for when purchasing Canadian prescription drugs over the internet. Big Mountain Drugs has some advice for consumers who want to be sure they are dealing with a legitimate Canadian drug store, and not a rogue pharmacy.
Read more…
PMG Report: In Columbus for his annual “Arnold Sports Festival”, Governor Arnold Schwarzenegger was asked to comment on recent political developments that have threatened to impact the multi-billion dollar sports nutrition and supplementation industry. During a live telecast of the event, host Dan Solomon asked Schwarzenegger about Washington’s involvement in the nutrition and supplementation industry.
The Governor responded, “Because the special interests, the pharmaceuticals, have been trying to make the legislators and the politicians in Washington always go and regulate food supplements and the nutrition business. And every five years you see an attack like that.”
D-Psoria products are the first topical, non-prescription cosmeceuticals for the redness, scaling and flaking associated with severe skin conditions. Developed by Astrel Genome Ltd., D-Psoria is being marketed in the U.S. by MediNiche Pharmaceuticals, St. Louis, Missouri.
D-Psoria products were developed in conjunction with doctors, estheticians and ayurvedic (science of life) natural principles. All products utilize natural ingredients, unique herbal extracts and key minerals, that when applied topically are designed specifically to help regenerate new, healthy skin.
D-Psoria is ideal for use by patients and consumers that wish to try a natural product as an alternative prior to considering prescription drug therapy. It is being promoted to medical and skincare professionals for recommendation to patients and consumers as a pre-pharmacotherapy consideration.
(Source) Press
Freezing of Gait (FOG) is an often incapacitating symptom common in Parkinson’s disease. Parkinson’s patients experiencing FOG feel as if their feet are glued to the floor. Will power to keep moving has no effect, leaving the Parkinson’s patient frozen in place. The associated physical and psychosocial consequences have a great impact on the patients’ quality of life, and injuries are common as the end result is often falling.
Neurologists prescribe pharmaceuticals commonly causing an array of side effects including mood changes and hallucinations. Furthermore, at advanced stages, FOGs are resistant to treatment with medications.
The resultant loss of independence and treatment costs of injuries add substantially to the health care expenditures associated with Parkinson’s disease.
Doctors have known for over 50 years that Parkinson’s patients suffering from FOG can walk almost normally when certain visual cues are placed in their path. The use of tranverse lines drawn on the floor have been studied extensively with good results.
Some challenges have kept this treatment strategy from leaving the clinical study setting:
The GaitAid device was developed to provide the benefits of this treatment strategy while solving these problems. It provides easy to use state of the art technology to display these cues through special glasses. The device provides cues which are automatically appropriate for each step taken no matter how big or fast. It is like having an expert physical therapist at your disposal drawing the cue needed for your next step just where it needs to be. In addition, clinical research has shown that, by providing separate cues for each foot as provided by the GaitAid, the improvement is two fold what was achieved by the transverse lines (same for both feet) strategy.
The GaitAid is the first device to offer a lasting improvement in walking as opposed to other devices on the market targeting FOG. With the GaitAid, one has the opportunity to train and improve so that later improved walking is possible without the device.
